A pilot test of a combined tobacco dependence treatment and lung cancer screening program
- PMID:22088938
- PMCID: PMC4272196
- DOI: 10.1016/j.lungcan.2011.10.011
A pilot test of a combined tobacco dependence treatment and lung cancer screening program
Abstract
Lung cancer screening with computed tomography has demonstrated a significant reduction in mortality. While these findings are important for the lung cancer research field, the most important risk factor for lung cancer, i.e. smoking, should not be ignored. We performed a pilot study to examine the feasibility of delivering a program that included both tobacco dependence treatment and lung cancer screening. The objectives of this study were to: (1) estimate the proportion of smokers who complied with a 12-week treatment protocol that included both tobacco dependence treatment and lung cancer screening, (2) obtain preliminary estimates of abstinence and quit attempts at 4 and 6 months, and (3) obtain preliminary estimates of the cognitive social health information processing (C-SHIP) constructs and how they change following the intervention. In this randomized pilot study, 18 volunteers completed a 12-week protocol: half received the tobacco dependence treatment program before a CT scan (BCT) and the other received the CT scan first, followed by the treatment program (ACT). The treatment protocol included both nurse-delivered telephone counseling and either nicotine replacement therapy or varenicline. Only one person did not complete all follow-up evaluations. At 4 months post enrollment, the carbon monoxide confirmed quit rates were 33.3% in the BCT arm and 22.2% in the ACT arm (27.8% overall), and all but one had made a 24-h attempt to quit. At 6 months the confirmed abstinence decreased to 22.1% in the BCT arm and 11.1% in the ACT arm (16.7% overall), and 72.2% of participants had made a 24-h quit attempt. These preliminary results suggest that it might be better to deliver treatment before the screening test. Future randomized trials with a larger sample size are needed to confirm these findings.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.
Conflict of interest statement
The authors have no conflicts of interest to report.
Figures
Similar articles
- A smoking cessation intervention for thoracic surgery and oncology clinics: a pilot trial.Park ER, Japuntich S, Temel J, Lanuti M, Pandiscio J, Hilgenberg J, Davies D, Dresler C, Rigotti NA.Park ER, et al.J Thorac Oncol. 2011 Jun;6(6):1059-65. doi: 10.1097/JTO.0b013e318215a4dc.J Thorac Oncol. 2011.PMID:21512406Free PMC article.Clinical Trial.
- Efficacy of varenicline combined with nicotine replacement therapy vs varenicline alone for smoking cessation: a randomized clinical trial.Koegelenberg CF, Noor F, Bateman ED, van Zyl-Smit RN, Bruning A, O'Brien JA, Smith C, Abdool-Gaffar MS, Emanuel S, Esterhuizen TM, Irusen EM.Koegelenberg CF, et al.JAMA. 2014 Jul;312(2):155-61. doi: 10.1001/jama.2014.7195.JAMA. 2014.PMID:25005652Clinical Trial.
- Internet versus in-person counseling for patients taking varenicline for smoking cessation.Dezee KJ, Wink JS, Cowan CM.Dezee KJ, et al.Mil Med. 2013 Apr;178(4):401-5. doi: 10.7205/MILMED-D-12-00272.Mil Med. 2013.PMID:23707824Clinical Trial.
- Nicotine receptor partial agonists for smoking cessation.Cahill K, Stead LF, Lancaster T.Cahill K, et al.Cochrane Database Syst Rev. 2012 Apr 18;(4):CD006103. doi: 10.1002/14651858.CD006103.pub6.Cochrane Database Syst Rev. 2012.Update in:Cochrane Database Syst Rev. 2016 May 09;(5):CD006103. doi: 10.1002/14651858.CD006103.pub7.PMID:22513936Updated.Review.
- Nicotine receptor partial agonists for smoking cessation.Cahill K, Stead LF, Lancaster T.Cahill K, et al.Cochrane Database Syst Rev. 2011 Feb 16;(2):CD006103. doi: 10.1002/14651858.CD006103.pub5.Cochrane Database Syst Rev. 2011.Update in:Cochrane Database Syst Rev. 2012 Apr 18;(4):CD006103. doi: 10.1002/14651858.CD006103.pub6.PMID:21328282Updated.Review.
Cited by
- Predictors of Enrollment of Older Smokers in Six Smoking Cessation Trials in the Lung Cancer Screening Setting: The Smoking Cessation at Lung Examination (SCALE) Collaboration.Eyestone E, Williams RM, Luta G, Kim E, Toll BA, Rojewski A, Neil J, Cinciripini PM, Cordon M, Foley K, Haas JS, Joseph AM, Minnix JA, Ostroff JS, Park E, Rigotti N, Sorgen L, Taylor KL.Eyestone E, et al.Nicotine Tob Res. 2021 Nov 5;23(12):2037-2046. doi: 10.1093/ntr/ntab110.Nicotine Tob Res. 2021.PMID:34077535Free PMC article.
- A protocol for a cluster randomized trial of care delivery models to improve the quality of smoking cessation and shared decision making for lung cancer screening.Lowenstein LM, Shih YT, Minnix J, Lopez-Olivo MA, Maki KG, Kypriotakis G, Leal VB, Shete SS, Fox J, Nishi SP, Cinciripini PM, Volk RJ.Lowenstein LM, et al.Contemp Clin Trials. 2023 May;128:107141. doi: 10.1016/j.cct.2023.107141. Epub 2023 Mar 5.Contemp Clin Trials. 2023.PMID:36878389Free PMC article.
- Incorporating a Smoking Cessation Intervention into Lung Cancer Screening Programs: Preliminary Studies.Hagerman CJ, Tomko CA, Stanton CA, Kramer JA, Abrams DB, Anderson ED, Taylor KL.Hagerman CJ, et al.J Psychosoc Oncol. 2015;33(6):703-23. doi: 10.1080/07347332.2015.1082171.J Psychosoc Oncol. 2015.PMID:26600242Free PMC article.
- Pairing smoking-cessation services with lung cancer screening: A clinical guideline from the Association for the Treatment of Tobacco Use and Dependence and the Society for Research on Nicotine and Tobacco.Fucito LM, Czabafy S, Hendricks PS, Kotsen C, Richardson D, Toll BA; Association for the Treatment of Tobacco Use and Dependence/Society for Research on Nicotine and Tobacco Synergy Committee.Fucito LM, et al.Cancer. 2016 Apr 15;122(8):1150-9. doi: 10.1002/cncr.29926. Epub 2016 Feb 24.Cancer. 2016.PMID:26916412Free PMC article.Review.
- Preliminary evaluation of a telephone-based smoking cessation intervention in the lung cancer screening setting: A randomized clinical trial.Taylor KL, Hagerman CJ, Luta G, Bellini PG, Stanton C, Abrams DB, Kramer JA, Anderson E, Regis S, McKee A, McKee B, Niaura R, Harper H, Ramsaier M.Taylor KL, et al.Lung Cancer. 2017 Jun;108:242-246. doi: 10.1016/j.lungcan.2017.01.020. Epub 2017 Feb 15.Lung Cancer. 2017.PMID:28216065Free PMC article.Clinical Trial.
References
- Hahn EJ, Rayens MK, Hopenhayn C, Christian WJ. Perceived risk and interest in screening for lung cancer among current and former smokers. Res Nurs Health. 2006;29:359–70. - PubMed
- Schnoll RA, Bradley P, Miller SM, Unger M, Babb J, Cornfeld M. Psychological issues related to the use of spiral CT for lung cancer early detection. Lung Cancer. 2003;39:315–25. - PubMed
- Taylor KL, Sanderson L, Zincke N, Mehta L, McGuire C, Gelmann E. Lung cancer screening as a teachable moment for smoking cessation. Lung Cancer. 2007;56:125–34. - PubMed
- Ostroff JS, Buckshee N, Mancuso CA, Yankelevitz DF, Henschke CI. Smoking cessation following CT screening for early detection of lung cancer. Prev Med. 2001;33:613–21. - PubMed
Publication types
MeSH terms
Substances
Related information
Grants and funding
LinkOut - more resources
Full Text Sources
Medical